EPISODE · Nov 4, 2024 · 18 MIN
Recaticimab as add-on therapy to statins for non-familial hypercholesterolaemia: the phase 3 REMAIN-2 trial
from JACC This Week
In this episode, Dr. Valentin Fuster reviews two pivotal phase three trials from China assessing the efficacy of the new monoclonal antibody, Katisha, for treating non-familial hypercholesterolemia. With significant reductions in LDL cholesterol and a long-acting, flexible dosing regimen, these studies promise a novel therapeutic option for patients struggling with cholesterol management and adherence to traditional treatments.
NOW PLAYING
Recaticimab as add-on therapy to statins for non-familial hypercholesterolaemia: the phase 3 REMAIN-2 trial
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m